DERMATOLOGICALS IN CROATIA

Euromonitor International

January 2019

LIST OF CONTENTS AND TABLES

Headlines

Prospects

Dermatologicals Not A Good Area for Non-prescription Medicine

Humble Reach of Paediatric Dermatologicals

Two Possible Trends for the Future

Competitive Landscape

Versatility of Bepanthen

Important Antifungals

Local Companies Almost Invisible

Category Data

Table 1 Sales of Dermatologicals by Category: Value 2013-2018

Table 2 Sales of Dermatologicals by Category: % Value Growth 2013-2018

Table 3 NBO Company Shares of Dermatologicals: % Value 2014-2018

Table 4 LBN Brand Shares of Dermatologicals: % Value 2015-2018

Table 5 Forecast Sales of Dermatologicals by Category: Value 2018-2023

Table 6 Forecast Sales of Dermatologicals by Category: % Value Growth 2018-2023

Executive Summary

Still Plenty of Space for Growth

General Improvement in the Economy Supports Sales of Consumer Health Products

Problems With Parent Company Do Not Bother Pliva Hrvatska

Liberalisation of the Market Still Just A Wish

the Future To Be Very Much Shaped by Legislation

Appendix

OTC Registration and Classification

Vitamins and Dietary Supplements Registration and Classification

Self-medication/self-care and Preventive Medicine

Market Indicators

Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2013-2018

Table 8 Life Expectancy at Birth 2013-2018

Market Data

Table 9 Sales of Consumer Health by Category: Value 2013-2018

Table 10 Sales of Consumer Health by Category: % Value Growth 2013-2018

Table 11 NBO Company Shares of Consumer Health: % Value 2014-2018

Table 12 LBN Brand Shares of Consumer Health: % Value 2015-2018

Table 13 Penetration of Private Label by Category: % Value 2013-2018

Table 14 Distribution of Consumer Health by Format: % Value 2013-2018

Table 15 Distribution of Consumer Health by Format and Category: % Value 2018

Table 16 Forecast Sales of Consumer Health by Category: Value 2018-2023

Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2018-2023

Sources

Summary 1 Research Sources

Dermatologicals cover an area of personal health that is quite intimate in nature for the patient. Because of this, Croatians are not prone to experimenting with self-medication and rather resort to seeking advice from professionals. The patient’s comfort zone is quickly left if a condition develops and all the possibilities of self-medication are excluded. This, of course, affects sales of dermatologicals in a negative way. Consumers are also shy to explore new products and rather stick to stan...

Euromonitor International's Dermatologicals in Croatia report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2014-2018, allowing you to identify the sectors driving growth. Forecasts to 2023 illustrate how the market is set to change.

Product coverage: Antiparasitics/Lice (Head and Body) Treatments, Antipruritics, Cold Sore Treatments, Haemorrhoid Treatments, Hair Loss Treatments, Medicated Shampoos, Nappy (Diaper) Rash Treatments, Paediatric Dermatologicals, Topical Allergy Remedies/Antihistamines, Topical Antifungals, Topical Germicidals/Antiseptics, Vaginal Antifungals.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Dermatologicals market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.

Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.